Spatial multi-omics reveal intratumoral humoral immunity niches associated with tertiary lymphoid structures in pancreatic cancer immunotherapy pathologic responders
Dimitrios N. SidiropoulosiD, Sarah M. ShiniD, Meredith WetzeliD, Alexander A. GirgisiD, Daniel R. BergmaniD, Ludmila DanilovaiD, Susheel PerikalaiD, Daniel H. ShuiD, Janelle Marie MontagneiD, Atul M. DeshpandeiD, James M. LeathermaniD, Lucie DequiedtiD, Victoria JacobsiD, Aleksandra OgurtsovaiD, Guanglan MoiD, Xuan YuaniD, Dmitrijs LvovsiD, Genevieve Stein-O’BrieniD, Mark M. YarchoaniD, Qingfeng ZhuiD, Elizabeth I. HarperiD, Ashani T. WeeraratnaiD, Ashley L. KiemeniD, Elizabeth M. JaffeeiD, Lei ZhengiD, , Luciane Tsukamoto KagoharaiD
Abstract
Pancreatic adenocarcinoma (PDAC) is a rapidly progressing cancer that responds poorly to immunotherapies. Intratumoral tertiary lymphoid structures (TLS) have been associated with rare long-term PDAC survivors, but the role of TLS in PDAC and their spatial relationships within the context of the broader tumor microenvironment remain unknown. We generated a spatial multi-omics atlas encompassing 26 PDAC tumors from patients treated with combination immunotherapies. Using machine learning-enabled H&E image classification models and unsupervised gene expression matrix factorization methods for spatial transcriptomics, we characterized cellular states within TLS niches spanning across distinct morphologies and immunotherapies. Unsupervised learning generated a TLS-specific spatial gene expression signature that significantly associates with improved survival in PDAC patients. These analyses demonstrate TLS-associated intratumoral B cell maturation in pathological responders, confirmed with spatial proteomics and BCR profiling. Our study also identifies spatial features of pathologic immune responses, revealing TLS maturation colocalizing with IgG/IgA distribution and extracellular matrix remodeling. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=188 SRC="FIGDIR/small/613714v1_ufig1.gif" ALT="Figure 1"> View larger version (69K): org.highwire.dtl.DTLVardef@d5e1a5org.highwire.dtl.DTLVardef@1d14012org.highwire.dtl.DTLVardef@c57c6corg.highwire.dtl.DTLVardef@16baa56_HPS_FORMAT_FIGEXP M_FIG C_FIG HIGHLIGHTSO_LIIntegrated multi-modal spatial profiling of human PDAC tumors from neoadjuvant immunotherapy clinical trials reveal diverse spatial niches enriched in TLS. C_LIO_LITLS maturity is influenced by tumor location and the cellular neighborhoods in which TLS immune cells are recruited. C_LIO_LIUnsupervised machine learning of genome-wide signatures on spatial transcriptomics data characterizes the TLS-enriched TME and associates TLS transcriptomes with survival outcomes in PDAC. C_LIO_LIInteractions of spatially variable gene expression patterns showed TLS maturation is coupled with immunoglobulin distribution and ECM remodeling in pathologic responders. C_LIO_LIIntratumoral plasma cell and immunoglobin gene expression spatial dynamics demonstrate trafficking of TLS-driven humoral immunity in the PDAC TME. C_LI SignificanceWe report a spatial multi-omics atlas of PDAC tumors from a series of immunotherapy neoadjuvant clinical trials. Intratumorally, pathologic responders exhibit mature TLS that propagate plasma cells into malignant niches. Our findings offer insights on the role of TLS-associated humoral immunity and stromal remodeling during immunotherapy treatment.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Spatial immune architecture and tumor lineage programs jointly shape clinical outcomes in advanced pancreatic ductal adenocarcinoma
Hay Mar Oo, Tauangtham Anekpuritanang, … Somponnat Sampattavanich·bioRxiv·Jul 4, 2026
- Coordinated immune architecture underlies durable survival in pancreatic cancer
Nabeel Merali, Sakina Amin, … Adam Enver Frampton·bioRxiv·May 4, 2026
- Single-cell and spatially resolved atlas of pancreatic cancer reveals immunophenotypes associated with clinical outcome
Gabriel F. Pozo de Mattos P., Marvin Paulo Lins, … Cristina Bonorino·bioRxiv·Feb 8, 2025
- Spatial drivers and pre-cancer populations collaborate with the microenvironment in untreated and chemo-resistant pancreatic cancer
D. Cui Zhou, R. G. Jayasinghe, … Ch·bioRxiv·Jan 13, 2021
- Integrated spatial proteomics of human PDAC uncovers an expanded tumour-immune-stroma spectrum with genomic associations
Noor E. Shakfa, Ferris Nowlan, … Hartland Warren Jackson·bioRxiv·Aug 15, 2025
- High-Dimensional Protein Analysis Uncovers Distinct Immunological and Stromal Signatures Between Primary and Metastatic Pancreatic Ductal Adenocarcinoma
Emily R. Greene, Natalie K. Horvat, … Gregory B. Lesinski·bioRxiv·Apr 18, 2025